Cambridge Cancer Genomics (CCG.ai)

Read our latest blog post by our Business Development Intern, @Anni_Fortuny, where she discusses how #coronavirus affects our body and how the pandemic can impact #cancer patients and care. ccg.ai/blog/coronavir…

@Anni_Fortuny @NRPBIODTP Woo hoo!

I can't believe it's been 6 weeks since the start of my internship placement at @CCGenomics! Let's see if you can spot me on their website. Thanks @NRPBIODTP ✌️🏼☕️ ccg.ai/about/team

Interesting article in @guardian about research into a blood test that can identify more than 50 types of cancer using machine learning: theguardian.com/science/2020/m… You can read the full article in @Annals_Oncology here: annalsofoncology.org/article/S0923-… #machinelearning #oncology #heathcare

One of @merckgroup Accelerator's alumni is @CCGenomics, which is on a mission to ensure that each patient has the right drug, at the right time, to beat their #cancer. Check them out >> ccg.ai #merckaccelerator

This week we would like to highlight John Cassidy @jwc_science Co-founder and CEO @CCGenomics, @CorrosionRADAR and @CambridgeSpark from our #21toWatch long and shortlists ow.ly/RXOI50yQ207

Read our new blog post by our Patient Experience Researcher, Bobbie, where she discusses the notion of "fairness" in AI and the harmful effects of encoded inequality and algorithmic biases. #AI #blog #ML #ethics #data buff.ly/2XmAb2u

“It’s changed me because it’s changed the way I live my life. I’m the same but different." Julie Walters has shared more about her experience of having #bowelcancer in an interview. She was diagnosed with stage 3 bowel cancer in 2018. mirror.co.uk/3am/celebrity-…

We've published new updates on #COVID19 research at the Crick: 🔹 @TurajlicLab and @royalmarsdenNHS are looking at how COVID-19 is affecting cancer treatment 🔹 Our Biomolecular Modelling Lab is working with @hadeaninc on their models of how viruses spread crick.ac.uk/news/2020-03-1…

Read our latest newsletter rounding up all the CCG.ai news and updates from the last two weeks. Don’t forget to subscribe so you never miss an update! buff.ly/3bYpmrE

There's also a lovely piece on our partnership with Prof. Andrew Biankin's Precision-Panc clinical trial, which you can read on page 35.

We are excited to have been named on @businessweekly's Killer 50 for the second year running! You can see the full list including @PROWLER_IO, @Speechmatics, @CambConsultants and more on page 27. Congratulations to everyone on the list! epaper.businessweekly.co.uk/html5/reader/p…

It’s #BowelCancerAwarenessMonth. Read our short information guide on how to be Bowel Cancer Aware. #BowelCancerUK buff.ly/2OczyDh

Subscribe to our newsletter: a fortnightly digest of CCG.ai’s news and updates! buff.ly/2RiglAR

If you missed our news about CCG.ai's partnership with @CR_UK's Precision-Panc clinical trial led by Prof. Andrew Biankin, you can read the full press release over on our website: buff.ly/3cL041n

Read our latest newsletter rounding up all the CCG.ai news and updates from the last two weeks. Don’t forget to subscribe so you never miss an update! buff.ly/2Wa174M

Read about CCG.ai’s data-driven approach to the complex problem of predicting cancer tumour evolution in our blog post by our Data Scientist, Adnan. buff.ly/2sSwQLG

Subscribe to our newsletter: a fortnightly digest of CCG.ai’s news and updates! buff.ly/2RiglAR

Our latest newsletter is now available to read! A fortnightly digest with all of our news and updates. Don’t forget to subscribe! buff.ly/2vxVym5

This week, we're highlighting a piece by Bobbie, in which she delves into the predicaments at the heart of tech's institutionalisation of ethics. It's a long read, but an interesting look at how companies are establishing ethics practices and frameworks. ccg.ai/blog/tech-comp…